Machine Learning

A promising oral therapy for Huntington's disease has been deemed eligible for accelerated review in Australia, offering new hope for a breakthrough.

An Israeli startup claims its 'Artificial Expert Intelligence' autonomously achieved a 3.6x speedup over a decade of human-engineered NVIDIA code.

A new board certification in Disaster Medicine will equip physicians across 14 specialties to lead during crises, enhancing healthcare system resilience.

A new AI-powered platform from industry veterans promises to transform P&C insurance, offering smaller carriers the tools to compete with giants.

A next-gen drug for chronic hives shows superior, faster results than the long-standing standard of care, heralding a potential shift in allergy treatment.

MARSOC veterans secure $32M for Smack Technologies, an AI lab building a 'Decision Dominance' platform designed to reshape U.S. military strategy.

As SAB Biotherapeutics prepares for key investor talks, a closer look reveals its novel T1D therapy and the unique bovine tech aiming to change treatment.

A new study aims to confirm a novel immunotherapy's dramatic results in colorectal cancer, offering hope for patients with limited treatment options.

Amorepacific's research-backed brand IOPE arrives at Sephora, challenging the US anti-aging market with patented technology and accessible pricing.

Halia Therapeutics is betting on a novel target to fight chronic inflammation. At a key summit, it will pitch its unique approach for cancer, obesity, and Alzheimer's.

A major contract with HawkEye 360 signals Europe's urgent push for sovereign defense, using commercial satellites to monitor invisible threats from space.

As autonomous AI transforms industries, a critical talent gap emerges. A new program from Simplilearn and Microsoft aims to train the next-gen leaders.

A new integration brings AI-powered creative from social media to streaming giants like Prime Video, promising a new era of measurable, personalized ads.

Flare Therapeutics partners with Simplicis, moving from manual "human babysitting" to automated infrastructure to eliminate risk and scale drug discovery.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

Diga-Talk Solutions names John K. Sullivan its new CBO, leveraging his 30 years in fire service to revolutionize mission-critical communications.

Userful's Infinity Platform now offers secure, real-time Epic integration and AI, turning fragmented data into actionable insights for smarter patient care.

A new study reveals a massive shift in perception, with pro gaming now a top career choice for Gen Z, backed by a multi-billion dollar industry.

The firm's Mexican affiliate begins import permit registration, signaling a strategic move to unlock cross-border trade and near-shoring manufacturing.

A new partnership brings advanced, non-invasive Alzheimer's blood tests to community centers, aiming for mass early detection and reshaping diagnostics.